Aurora Cannabis Signs Agreement with Heinrich Klenk GmbH & Co. KG
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced that the Company, through its wholly owned subsidiary Pedanios GmbH, has signed a collaboration agreement with Heinrich Klenk GmbH & Co. KG, one of Europe’s largest medicinal plant companies. Klenk, whose products are carried in over 25,000 pharmacies throughout Germany and Europe,... Read more
Pharmacists urge Senate to include more support for patients as they consider Bill C-45 to legalize cannabis
With the legalization of recreational cannabis looming on the horizon, the Canadian Pharmacists Association (CPhA), joined by the Association québécoise des pharmaciens propriétaires (AQPP), appeared today before the Standing Senate Committee on Social Affairs, Science and Technology to discuss Bill C-45. Pharmacists are asking the Senate to include more... Read more
Liberty Health Sciences Signs Exclusive Agreement to Bring Award-Winning Mary’s Medicinals Cannabis Products to Massachusetts
Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF) today announced the expansion of the Company’s partnership with Colorado-based MM Technology Holdings, LLC to be the exclusive provider of the award-winning line of Mary’s Medicinals® cannabis products in Massachusetts. Under the agreement, Liberty will produce and distribute Mary’s suite of innovative cannabis... Read more
Aurora Cannabis Retains KCSA Strategic Communications to Enhance U.S. investor and Media Outreach
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) today announced it has appointed retained KCSA Strategic Communications, a leading New York-based communications firm, to support the Company’s strategic communications and investor relations efforts in the United States. “With American investor interest in Aurora growing rapidly, and a number of significant... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )